Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
386.73
-1.30 (-0.34%)
At close: Jun 30, 2026, 4:00 PM EDT
384.00
-2.73 (-0.71%)
After-hours: Jun 30, 2026, 7:45 PM EDT

Elevance Health Stock Forecast

Stock Price Forecast

According to 22 analysts polled by S&P Global, Elevance Health stock has a consensus rating of "Buy" and an average price target of $418.67. The average 1-year stock price forecast is 8.26% higher than the current stock price, while the lowest is $331 (-14.41%) and the highest is $498 (+28.77%).

Price Target: $418.67 (+8.26%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$331$418.67$404$498
Change-14.41%+8.26%+4.47%+28.77%

Analyst Ratings

The average analyst rating for Elevance Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy111111111212
Buy433332
Hold788878
Sell000000
Strong Sell000000
Total222222222222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Barclays
Barclays
Buy
Maintains
$480
BuyMaintains$480+24.12%Jun 11, 2026
Bernstein
Bernstein
Buy
Maintains
$424
BuyMaintains$424+9.64%Jun 9, 2026
J.P. Morgan
J.P. Morgan
Buy
Maintains
$411$476
BuyMaintains$411$476+23.08%Jun 8, 2026
Mizuho Securities
Mizuho Securities
Buy
Maintains
$435$465
BuyMaintains$435$465+20.24%Jun 8, 2026
Wells Fargo
Wells Fargo
Buy
Maintains
$391
BuyMaintains$391+1.10%Jun 4, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
194.30B
from 199.13B
Decreased by -2.42%
Revenue Next Year
198.71B
from 194.30B
Increased by 2.27%
EPS This Year
26.90
from 30.29
Decreased by -11.18%
EPS Next Year
29.25
from 26.90
Increased by 8.71%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
138.64B156.60B171.34B176.81B199.13B194.30B
Revenue Growth
13.77%12.95%9.41%3.19%12.62%-2.42%
Net Income
6.16B5.89B5.99B5.98B5.66B4.50B
EPS
----30.2926.90
EPS Growth
-----8.32%-11.18%
Forward PE
16.7016.1413.1711.2513.0914.37
Dividend / Share
4.525.125.926.526.846.96
Dividend Growth
-13.27%15.62%10.14%4.91%1.73%
Free Cash Flow
3.61B8.43B3.00B7.26B3.40B6.21B
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High197.9B
Avg194.3B
Low190.0B

Revenue Growth

Revenue Growth202620272028
High
-0.6%
Avg
-2.4%
Low
-4.6%

EPS Forecast

EPS202620272028
High28.25
Avg26.90
Low26.72

EPS Growth

EPS Growth202620272028
High
-6.7%
Avg
-11.2%
Low
-11.8%